Wutah dodolan YoY sajrone 12 wulan kepungkur: Sutro Biopharma, Inc. (STRO)

Logo perusahaan publik Sutro Biopharma, Inc (STRO)

Sutro Biopharma, Inc. (STRO) revenues rely on partner payments, as the retail market remains inaccessible. The year-over-year revenue change over the trailing twelve months (TTM) clearly demonstrates this process, with the metric standing at -56.70. Sutro Biopharma, Inc. (STRO) is implementing its unique XpressCF protein synthesis to combat cancer, although financial stability currently depends entirely on external funding and clinical trial results.

Wutah pendapatan YoY sajrone 12 wulan kepungkur Sutro Biopharma (STRO): kanggo periode 11.02.2024 - 17.11.2026

Sutro Biopharma (STRO) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:
Ringkesan analitik perusahaan:Sutro Biopharma, Inc.
Sampel barang sutrobio.com

The development of ADC drugs and partner advances define the financial profile of Sutro Biopharma, Inc. (STRO). Year-over-year sales dynamics over the last four quarters measure the percentage change in TTM revenue, reflecting the actual pace of business scaling. Growth in this indicator confirms the commercial demand for cell-free protein synthesis. The steady acceleration on the chart signals the viability of the model. Investors use this trend to assess the fundamental value of the asset.

Pesaing Sutro Biopharma, Inc. (STRO)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IOVA - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMTX (Immatics Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur XNCR|Wutah dodolan YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur REPL|lyell.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Innate Pharma S.A|Pyxis (PYXS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Compugen Ltd - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|IOBT (iobiotech.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) MiNK Therapeutics Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur werewolftx.com (HOWL)|IMMX: Wutah dodolan taun lumaku|alxoncology.com - Wutah pendapatan YoY sajrone 12 wulan kepungkur|CUE - Wutah pendapatan YoY sajrone 12 wulan kepungkur|PDSB - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur Sonnet BioTherapeutics Holdings SONN|MAIA: Wutah dodolan YoY (TTM)|LIMN - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur LVTX|Wutah dodolan YoY sajrone 12 wulan kepungkur NXTC (NextCure)|Wutah dodolan YoY sajrone rolas wulan kepungkur leaptx.com (LPTX)|INTS - Wutah pendapatan taun lumaku|Wutah dodolan YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Theriva Biologics, Inc. (TOVX)|GRTS: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur kinetabio.com KA|NEXI (neximmune.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur